Adhesive threads of extraintestinal pathogenic Escherichia coli

The ability to adhere to host surfaces is by far the most vital step in the successful colonization by microbial pathogens. Colonization begins with the attachment of the bacterium to receptors expressed by cells forming the lining of the mucosa. Long hair like extracellular appendages called fimbriae, produced by most Gram-negative pathogens, mediate specific attachment to the epithelial cell surface. Associated with the fimbriae is a protein called an adhesin, which directs high-affinity binding to specific cell surface components. In the last couple of years, an enormous amount of research has been undertaken that deals with understanding how bacterial pathogens adhere to host cells. E. coli in all probability is one of the best studied free-living organisms. A group of E. coli called Extraintestinal pathogenic E. coli (ExPEC) including both human and animal pathogens like Uropathogenic E. coli (UPEC), Newborn meningitic E. coli (NMEC) and Avian pathogenic E. coli (APEC), have been found to harbour many fimbriae including Type 1 fimbriae, P fimbriae, curli fibres, S fimbriae, F1C fimbriae, Dr fimbriae, afimbrial adhesins, temperature-sensitive haemagglutinin and many novel adhesin gene clusters that have not yet been characterized. Each of these adhesins is unique due to the recognition of an adhesin-specific receptor, though as a group these adhesins share common genomic organization. A newly identified putative adhesin temporarily termed ExPEC Adhesin I, encoded by gene yqi, has been recently found to play a significant role in the pathogenesis of APEC infection, thus making it an interesting candidate for future research. The aim of this review is to describe the role of ExPEC adhesins during extraintestinal infections known till date, and to suggest the idea of investigating their potential role in the colonization of the host gut which is said to be a reservoir for ExPEC

Reflections from the COVID-19 pandemic in Germany: lessons for global health

Trust is crucial to handling any global health crisis; the expertise and sustainability of National Public Health Institutions is the basis for trust building. Public health requires citizens to make the right individual choices that have a positive domino effect on the general population. Communication, therefore, plays an essential role. Public health systems must be strengthened and stronger public health systems must assist weaker ones in an act of global solidarity. Digitalising healthcare and public health will play a fundamental role in strengthening public health systems and thus in handling future crises

Anwendungsbereiche von künstlicher Intelligenz im Kontext von One Health mit Fokus auf antimikrobielle Resistenzen

Die Gesundheit der Menschen steht vor einer Reihe neuer Herausforderungen, die maßgeblich durch den fortschreitenden Klimawandel, den demografischen Wandel und die Globalisierung angetrieben werden. Der One-Health-Ansatz basiert auf dem Verständnis, dass die Gesundheit von Menschen, Tieren und Umwelt eng verknüpft ist. Bei der Umsetzung von One Health in die Praxis ergibt sich die Notwendigkeit, in der Forschung diverse und heterogene Datenströme und -typen aus den verschiedenen Sektoren zu kombinieren und zu analysieren. Verfahren der künstlichen Intelligenz (KI) bieten dabei neue Möglichkeiten zur sektorübergreifenden Beurteilung von heutigen und zukünftigen Gesundheitsgefahren. Dieser Beitrag gibt einen Überblick über verschiedene Anwendungsbereiche von KI-Verfahren im Zusammenhang mit One Health und zeigt Herausforderungen auf. Am Beispiel der Ausbreitung antimikrobieller Resistenzen (AMR), die eine zunehmende globale Gefahr im One-Health-Kontext darstellt, werden bestehende und zukünftige KI-basierte Lösungsansätze zur Eindämmung und Prävention beschrieben. Diese reichen von neuartiger Arzneientwicklung und personalisierter Therapie über gezieltes Monitoring der Antibiotikanutzung in Tierhaltung und Landwirtschaft bis hin zu einer umfassenden Umwelt-Surveillance für zukünftige AMR-Risikobewertungen.Societal health is facing a number of new challenges, largely driven by ongoing climate change, demographic ageing, and globalization. The One Health approach links human, animal, and environmental sectors with the goal of achieving a holistic understanding of health in general. To implement this approach, diverse and heterogeneous data streams and types must be combined and analyzed. To this end, artificial intelligence (AI) techniques offer new opportunities for cross-sectoral assessment of current and future health threats. Using the example of antimicrobial resistance as a global threat in the One Health context, we demonstrate potential applications and challenges of AI techniques. This article provides an overview of different applications of AI techniques in the context of One Health and highlights their challenges. Using the spread of antimicrobial resistance (AMR), an increasing global threat, as an example, existing and future AI-based approaches to AMR containment and prevention are described. These range from novel drug development and personalized therapy, to targeted monitoring of antibiotic use in livestock and agriculture, to comprehensive environmental surveillance.Peer Reviewe

Signature-Tagged Mutagenesis in a Chicken Infection Model Leads to the Identification of a Novel Avian Pathogenic Escherichia coli Fimbrial Adhesin

The extraintestinal pathogen, avian pathogenic E. coli (APEC), known to cause systemic infections in chickens, is responsible for large economic losses in the poultry industry worldwide. In order to identify genes involved in the early essential stages of pathogenesis, namely adhesion and colonization, Signature-tagged mutagenesis (STM) was applied to a previously established lung colonization model of infection by generating and screening a total of 1,800 mutants of an APEC strain IMT5155 (O2:K1:H5; Sequence type complex 95). The study led to the identification of new genes of interest, including two adhesins, one of which coded for a novel APEC fimbrial adhesin (Yqi) not described for its role in APEC pathogenesis to date. Its gene product has been temporarily designated ExPEC Adhesin I (EA/I) until the adhesin-specific receptor is identified. Deletion of the ExPEC adhesin I gene resulted in reduced colonization ability by APEC strain IMT5155 both in vitro and in vivo. Furthermore, complementation of the adhesin gene restored its ability to colonize epithelial cells in vitro. The ExPEC adhesin I protein was successfully expressed in vitro. Electron microscopy of an afimbriate strain E. coli AAEC189 over-expressed with the putative EA/I gene cluster revealed short fimbrial-like appendages protruding out of the bacterial outer membrane. We observed that this adhesin coding gene yqi is prevalent among extraintestinal pathogenic E. coli (ExPEC) isolates, including APEC (54.4%), uropathogenic E. coli (UPEC) (65.9%) and newborn meningitic E. coli (NMEC) (60.0%), and absent in all of the 153 intestinal pathogenic E. coli strains tested, thereby validating the designation of the adhesin as ExPEC Adhesin I. In addition, prevalence of EA/I was most frequently associated with the B2 group of the EcoR classification and ST95 complex of the multi locus sequence typing (MLST) scheme, with evidence of a positive selection within this highly pathogenic complex. This is the first report of the newly identified and functionally characterized ExPEC adhesin I and its significant role during APEC infection in chickens

Identification of avian pathogenic E. coli (APEC) genes important for the colonization of the chicken lung and characterization of the novel ExPEC adhesin I

Aviäre pathogene E. coli (APEC) sind extraintestinale Pathogene, die beim Huhn systemische Infektionskrankheiten hervorrufen. Zur Identifizierung Gene, die an der Kolonisierung des Wirtes beteiligt sind, wurde ein Lungen-Infektionsmodell in 5 Wochen alten SPF Hühnern etabliert. In dem Modell wurden 1.800 mittels Signature-tagged-Mutagenese (STM) hergestellten Mutanten des APEC Stamms IMT5155 (O2:K1:H5; ST-Komplex 95) auf ihre Fähigkeit zur Kolonisierung getestet. Die Untersuchung führte zur Identifizierung Gene, einschließlich Adhäsin-, LPS- und Kapsel-bildenden Genen, sowie Genen mit putativer Funktion. Die STM-Analyse erlaubte zudem die Identifizierung eines zuvor nicht charakterisierten putativen Fimbrien-bildenden Adhäsins (Yqi). Das Genprodukt wurde vorläufig als ExPEC Adhäsin I (EA/I) bezeichnet. Eine Deletion des EA/I-Gens führte zu einer Reduzierung der Adhäsionsfähigkeit des Stammes IMT5155 in vitro und in vivo. Eine Komplementierung des EA/I-Gens in trans resultierte in einer Wiederherstellung des Adhäsions¬vermögens in vitro. Das EA/I-Protein (~39 kDa) wurde als Fusionsprotein in vitro exprimiert, und mittels SDS-PAGE und Western Blot nachgewiesen. Durch Überexpression des EA/I-Operons in dem Fimbrien-negativen E. coli-Stamm AAEC189 konnten mittels elektronenmikroskopischer Aufnahmen Fimbrien-bildende Strukturen auf der äußeren Membran dargestellt werden. Das Vorkommen des yqi in den untersuchten extraintestinal pathogenen E. coli (ExPEC), bei gleichzeitigem Fehlen in allen untersuchten intestinal pathogenen E. coli bestätigt die Bezeichnung ExPEC Adhäsin I. Die Prävalenz des EA/I-Gens war am stärksten assoziiert mit Stämmen der B2-Phylogenetische-Gruppe und des ST95-Komplexes des Multi-Lokus-Sequenz-Typisierungs (MLST)-Schemas. Sequenzanalysen ergaben zudem erste Hinweise auf eine positive Selektion des EA/I-Gens innerhalb dieses Komplexes. In der vorliegenden Arbeit gelang somit die Identifizierung und Charakterisierung des neuen ExPEC Adhäsin I.The extraintestinal pathogen, avian pathogenic E. coli (APEC), known to cause systemic infections in chickens, is responsible for large economic losses in the poultry industry. To identify genes, involved adhesion and colonization, a lung colonization model of infection was established in 5-week old specific-pathogen free (SPF) chickens, and Signature-tagged mutagenesis (STM) was applied to this model by generating and screening a total of 1,800 mutants of an APEC strain IMT5155 (O2:K1:H5; ST complex 95). This led to the identification of new genes of interest, including adhesins, genes involved in capsule and LPS formation, and genes of putative function. Among the many genes identified was one coding for a novel APEC fimbrial adhesin (Yqi) not described for its role in APEC pathogenesis. Its gene product was temporarily designated ExPEC Adhesin I (EA/I). Deletion of the ExPEC adhesin I gene resulted in reduced colonization ability by APEC strain IMT5155 both in vitro and in vivo. Complementation of the adhesin gene restored its ability to colonize epithelial cells in vitro. The ExPEC adhesin I protein (~ 39 kDa) was expressed as a fusion protein in vitro as shown by SDS-PAGE and western blotting. Electron microscopy of an afimbriate strain E. coli AAEC189 over-expressed with the putative EA/I gene cluster revealed short fimbrial like appendages protruding out of the bacterial outer membrane. We observed that the adhesin coding gene yqi is prevalent among extraintestinal pathogenic E. coli (ExPEC) isolates and absent in all of the intestinal pathogenic E. coli strains tested, thereby validating the designation of the adhesin as ExPEC Adhesin I. In addition, prevalence of EA/I was most frequently associated with the E. coli phylogenetic group B2 and ST95 complex of the multi locus sequence typing (MLST) scheme, with evidence of a positive selection within this complex. This is the first report of the newly identified and functionally characterized ExPEC adhesin I

SARS-CoV-2: Testergebnisse richtig einordnen

Diagnostische Antigen-Tests („Schnelltests“) können dabei helfen, akut mit SARS-CoV-2 infizierte Personen zu identifizieren. Sie weisen SARS-CoV-2-Proteine nach und sind schneller und preiswerter als PCR-Tests. Gegenwärtig bieten etwa einhundert Unternehmen Schnelltests zum Nachweis von SARS-CoV-2-Antigenen an (1). Um die Testergebnisse richtig einordnen zu können, müssen zwei Fragen beantwortet werden können: Zum einen: Wenn der Test positiv ist, wie wahrscheinlich ist es, dass der oder die Getestete tatsächlich akut infiziert ist? Und zum anderen: Wenn der Test negativ ist, wie wahrscheinlich ist es, dass der oder die Getestete tatsächlich nicht akut infiziert ist? Im Folgenden wird erläutert, weshalb die Aussagekraft von Antigen-Schnelltest-Resultaten stark davon abhängt, wie viele der Getesteten tatsächlich infiziert sind. Die Antworten auf die beiden Fragen hängen zum Teil von den Testgütekriterien Sensitivität und Spezifität ab: Die Sensitivität (Richtig-Positiv-Rate) eines Tests beschreibt seine Fähigkeit, mit SARS-CoV-2 infizierte Personen korrekt zu identifizieren. Die Spezifität (Richtig-Negativ-Rate) eines Tests beschreibt seine Fähigkeit, diejenigen Personen korrekt zu identifizieren, die nicht mit SARS-CoV-2 infiziert sind.Peer Reviewe

Intestine and Environment of the Chicken as Reservoirs for Extraintestinal Pathogenic Escherichia coli Strains with Zoonotic Potential ▿ †

Although research has increasingly focused on the pathogenesis of avian pathogenic Escherichia coli (APEC) infections and the “APEC pathotype” itself, little is known about the reservoirs of these bacteria. We therefore compared outbreak strains isolated from diseased chickens (n = 121) with nonoutbreak strains, including fecal E. coli strains from clinically healthy chickens (n = 211) and strains from their environment (n = 35) by determining their virulence gene profiles, phylogenetic backgrounds, responses to chicken serum, and in vivo pathogenicities in a chicken infection model. In general, by examining 46 different virulence-associated genes we were able to distinguish the three groups of avian strains, but some specific fecal and environmental isolates had a virulence gene profile that was indistinguishable from that determined for outbreak strains. In addition, a substantial number of phylogenetic EcoR group B2 strains, which are known to include potent human and animal extraintestinal pathogenic E. coli (ExPEC) strains, were identified among the APEC strains (44.5%) as well as among the fecal E. coli strains from clinically healthy chickens (23.2%). Comparably high percentages (79.2 to 89.3%) of serum-resistant strains were identified for all three groups of strains tested, bringing into question the usefulness of this phenotype as a principal marker for extraintestinal virulence. Intratracheal infection of 5-week-old chickens corroborated the pathogenicity of a number of nonoutbreak strains. Multilocus sequence typing data revealed that most strains that were virulent in chicken infection experiments belonged to sequence types that are almost exclusively associated with extraintestinal diseases not only in birds but also in humans, like septicemia, urinary tract infection, and newborn meningitis, supporting the hypothesis that not the ecohabitat but the phylogeny of E. coli strains determines virulence. These data provide strong evidence for an avian intestinal reservoir hypothesis which could be used to develop intestinal intervention strategies. These strains pose a zoonotic risk because either they could be transferred directly from birds to humans or they could serve as a genetic pool for ExPEC strains

Antibiotic resistance, the 3As and the road ahead

Abstract Antibiotic resistance is by far one of the most important health threats of our time. Only a global concerted effort of several disciplines based on the One-Health concept will help in slowing down this process and potentially mitigate the ruin of healthcare we have come to enjoy. In this review, we attempt to summarize the most basic and important topics that serve as good information tools to create Awareness. The Availability of antibiotics or the lack thereof is another significant factor that must be given thought, and finally because antibiotic resistance is a problem that will not go away, it is important to have Alternatives. Together, we have the 3As, essential concepts, in dealing with this growing and complex problem